EUVIMEDEUVIMED entdecken
Crossref

Study on the Mechanism of Dihydromyricetin in Alleviating Depressive-Like Behavior in Rats Based on Network Pharmacology

Xue Li, Miaoqi Chen, Decheng Wei, Pengsheng Wei, Yanzong Jiang, Jiaqi Chen, Xiaomeng Duan, Zitong Wang, Yuchuan Zhang, Dafeng Bai, Hui Jia, Ge Jin

Neurochemical Research · 2025-06 · 50 (3)

DOI: 10.1007/s11064-025-04419-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 26.05.2025. Verfasst von Xue Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Basic Medical School, Shenyang Medical College, 146 Huanghe North Street, Yuhong District, Shenyang, 110034, Liaoning, China. Hauptthemen laut MEDLINE: Flavonols, Network Pharmacology, Depression, Antidepressive Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Department of Education of Liaoning Province, Department of Science and Technology of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is a chronic and recurrent neuropsychiatric disorder with complex pathophysiology. Dihydromyricetin (DMY), a bioactive flavonoid compound isolated from Ampelopsis grossedentata (commonly known as rattan tea), has demonstrated multiple pharmacological properties including anti-inflammatory, antioxidant, antitumor, and antimicrobial activities. In the present study, a well-established rodent model of depression was generated through chronic unpredictable mild stress (CUMS) paradigm combined with social isolation. Following eight weeks of DMY intervention, comprehensive behavioral assessments were conducted to validate both the successful establishment of the depression model and the therapeutic efficacy of DMY treatment. We employed network pharmacology approaches to systematically predict potential antidepressant targets of DMY. Further mechanistic investigations were performed to elucidate the underlying molecular pathways, providing novel perspectives for developing innovative antidepressant therapeutics.Integrating network pharmacology prediction with molecular biology validation, our findings revealed that DMY exerts significant antidepressant-like effects through suppression of the advanced glycosylation end products (AGEs)-RAGE signaling pathway, activation of the nuclear factor E2-related factor 2 (NRF2)-mediated antioxidant defense system, and upregulation of synaptic plasticity-related proteins including postsynaptic density protein 95 (PSD95) and synaptophysin (SYP). These results suggest that DMY may represent a promising natural therapeutic candidate for depression treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonolsNetwork PharmacologyDepressionAntidepressive AgentsAnimalsMaleRats, Sprague-DawleyRatsSignal Transduction

Stichwörter der Autor:innen

Anti-inflammatoryDepressionDihydromyricetinNetwork pharmacologyOxidative stress

Substanzen

dihydromyricetinFlavonolsAntidepressive Agents

Autor:innen und Institutionen

  • Basic Medical School, Shenyang Medical College, 146 Huanghe North Street, Yuhong District, Shenyang, 110034, Liaoning, China.
  • School of Traditional Chinese Medicine, Shenyang Medical College, 146 Huanghe North Street, Yuhong District, Shenyang, 110034, Liaoning, China.
  • School of Pharmacy, Shenyang Medical College, 146 Huanghe North Street, Yuhong District, Shenyang, 110034, Liaoning, China.
  • The Eleventh People's Hospital of Shenyang, No. 31 Haitang Street, Shenyang, China. dafengbai@163.com.
  • School of Traditional Chinese Medicine, Shenyang Medical College, 146 Huanghe North Street, Yuhong District, Shenyang, 110034, Liaoning, China. huijia412413@symc.edu.cn.
  • Key Laboratory of Behavioral and Cognitive Neuroscience of Liaoning Province, Shenyang Medical College, 146 Huanghe North Street, Yuhong District, Shenyang, 110034, Liaoning, China. huijia412413@symc.edu.cn.

Förderung

  • Department of Education of Liaoning Province
  • Department of Science and Technology of Liaoning Province

Zitieren

APA

Li, X., Chen, M., Wei, D., Wei, P., Jiang, Y., Chen, J., Duan, X., Wang, Z., Zhang, Y., Bai, D., Jia, H., & Jin, G. (2025). Study on the Mechanism of Dihydromyricetin in Alleviating Depressive-Like Behavior in Rats Based on Network Pharmacology. Neurochemical Research, 50(3). https://doi.org/10.1007/s11064-025-04419-6

Vancouver

Li X, Chen M, Wei D, Wei P, Jiang Y, Chen J, et al. Study on the Mechanism of Dihydromyricetin in Alleviating Depressive-Like Behavior in Rats Based on Network Pharmacology. Neurochemical Research. 2025;50(3). doi:10.1007/s11064-025-04419-6

BibTeX
@article{Li2025,
  author = {Li, Xue and Chen, Miaoqi and Wei, Decheng and Wei, Pengsheng and Jiang, Yanzong and Chen, Jiaqi and Duan, Xiaomeng and Wang, Zitong and Zhang, Yuchuan and Bai, Dafeng and Jia, Hui and Jin, Ge},
  title = {Study on the Mechanism of Dihydromyricetin in Alleviating Depressive-Like Behavior in Rats Based on Network Pharmacology},
  journal = {Neurochemical Research},
  year = {2025},
  volume = {50},
  number = {3},
  doi = {10.1007/s11064-025-04419-6}
}
Kostenlos starten →